SuperNova Diagnostics® to Present at Biotech Showcase™ 2011 During J.P. Morgan Healthcare Conference January 10-13

WASHINGTON, LONDON and HONG KONG, Jan. 5, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced today that Neil J. Campbell, president and CEO, will present at Biotech Showcase 2011 in conjunction with the J.P. Morgan Healthcare Conference in San Francisco, CA.  

Mr. Campbell's presentation will be given at the Parc 55 Wyndham Hotel on Wednesday, January 12, 2011 at 3:30 p.m. PST.  "We are delighted to be presenting at a renowned conference such as Biotech Showcase," said Mr. Campbell.  "Biotech Showcase and the J.P. Morgan Healthcare Conference provide a unique opportunity to present to a diverse group of first-class investors and executives interested in medical and industrial diagnostics."

AmpCrystal®, SuperNova Diagnostics' lead technology and its multiple product formats, allows for minimally trained individuals (advanced CLIA-waived) to test for a wide range of protein analytes and can detect directly un-amplified DNA in humans, animals or environmental samples.  

Time-to-result has been shown in prototypes to be reduced to minutes on the spot versus the hours or days required when sending samples to a central laboratory or processing in regional satellite laboratories.  With three integrated capabilities (sample collector/processor, analytical disposable, and the readout device), the technology is simpler, more robust, faster and significantly less expensive than existing POC systems.

Significant advantages of AmpCrystals are direct detection of samples, simplification of product designs, ability to lower costs of delivery and broaden range of assay formats from the central laboratory.

About SuperNova Diagnostics®, Inc.

SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can delivery novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® - Putting the Laboratory in the Palm of Your Hand®.

For additional information, please visit www.supernovadiagnostics.com.

SOURCE SuperNova Diagnostics, Inc.